|
End-of-day quote
Moscow Micex - RTS
08/07/2022
|
5-day change | 1st Jan Change | ||
| 4.505 RUB | +10.15% |
|
-.--% | - |
| Market Cap | 1.98B 24.03M 21.83M 20.17M 18.22M 34.38M 2.26B 35.59M 243M 96.11M 1.21B 90.17M 88.26M 3.84B | P/E 2024 |
7.8x | P/E 2025 | -7.81x |
|---|---|---|---|---|---|
| Enterprise Value | 2.34B 28.39M 25.79M 23.83M 21.52M 40.62M 2.67B 42.04M 287M 114M 1.43B 107M 104M 4.53B | EV / Sales 2024 |
9.48x | EV / Sales 2025 | 15x |
| Free-Float |
95.22% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +10.15% |
| 5 years | 2.64 | 6.88 | |
| 10 years | 2.64 | 18.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 48 | 31/12/2013 | |
Alexey Shafranov
DFI | Director of Finance/CFO | 47 | - |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Dmitriy Genkin
CHM | Chairman | 57 | 31/12/2004 |
| Director/Board Member | 58 | - | |
Alexey Shafranov
BRD | Director/Board Member | 47 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +10.15% | -.--% | -.--% | -.--% | 25.27M | ||
| -0.82% | +1.40% | +39.64% | +143.17% | 1,275B | ||
| -1.12% | +0.16% | +44.21% | +88.24% | 680B | ||
| -0.16% | +0.43% | +26.76% | +113.01% | 521B | ||
| +1.14% | +2.04% | +43.06% | +72.81% | 389B | ||
| -2.23% | -2.89% | +55.47% | +41.64% | 356B | ||
| +1.27% | +1.72% | +30.01% | +63.11% | 305B | ||
| +0.37% | -0.23% | +3.71% | +38.05% | 287B | ||
| -0.72% | -0.63% | +37.29% | +71.87% | 250B | ||
| -0.30% | -1.03% | +34.04% | +124.88% | 208B | ||
| Average | +0.76% | +1.47% | +31.42% | +75.68% | 427B | |
| Weighted average by Cap. | -0.47% | +0.76% | +36.92% | +98.02% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 247M 3M 2.72M 2.51M 2.27M 4.29M 281M 4.44M 30.24M 11.98M 151M 11.24M 11M 478M | 156M 1.89M 1.72M 1.59M 1.43M 2.7M 177M 2.8M 19.06M 7.55M 95.16M 7.09M 6.94M 301M |
| Net income | 254M 3.08M 2.8M 2.59M 2.34M 4.41M 289M 4.56M 31.1M 12.32M 155M 11.56M 11.32M 492M | -254M -3.08M -2.79M -2.58M -2.33M -4.4M -289M -4.56M -31.04M -12.3M -155M -11.54M -11.3M -491M |
| Net Debt | 360M 4.36M 3.96M 3.66M 3.31M 6.24M 409M 6.46M 44.02M 17.44M 220M 16.36M 16.02M 696M | 360M 4.36M 3.96M 3.66M 3.3M 6.23M 409M 6.45M 43.97M 17.42M 219M 16.35M 16M 695M |
Employees
59
Sector
Pharmaceuticals
- Stock Market
- Stocks
- LIFE Stock
Select your edition
All financial news and data tailored to specific country editions
















